Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 6/20 | 0.48 |
| ▸ | ICAM1 | P05362 | 6/20 | 0.48 |
| ▸ | ITGAL | P20701 | 6/20 | 0.48 |
| ▸ | CAPN1 | P07384 | 5/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6497573 | 1.00 | ITGB2 (0.48) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL6506110 | 0.93 | CAPN1 (0.56) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL6506117 | 0.93 | CAPN1 (0.56) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL8297323 | 0.93 | CAPN1 (0.56) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL6505573 | 0.93 | CAPN1 (0.51) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL8298729 | 0.92 | ITGB2 (0.47) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL6503817 | 0.92 | ITGB2 (0.47) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL8296170 | 0.91 | ITGAL (0.50) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL6495393 | 0.91 | ITGAL (0.50) | ITGB2ICAM1ITGALCAPN1MAPK1 | |
| SCHEMBL6495389 | 0.91 | ITGAL (0.50) | ITGB2ICAM1ITGALCAPN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | claimed |